ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

NCYT Novacyt S.a.

61.20
0.40 (0.66%)
04 Oct 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Novacyt S.a. LSE:NCYT London Ordinary Share FR0010397232 EUR1/15TH (CDI)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.40 0.66% 61.20 61.60 63.80 64.60 61.60 62.60 107,324 16:35:29
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
In Vitro,in Vivo Diagnostics 11.58M -28.29M - N/A 42.94M
Novacyt S.a. is listed in the In Vitro,in Vivo Diagnostics sector of the London Stock Exchange with ticker NCYT. The last closing price for Novacyt was 60.80p. Over the last year, Novacyt shares have traded in a share price range of 40.00p to 137.00p.

Novacyt currently has 70,626,248 shares in issue. The market capitalisation of Novacyt is £42.94 million.

Novacyt Share Discussion Threads

Showing 8726 to 8744 of 73750 messages
Chat Pages: Latest  358  357  356  355  354  353  352  351  350  349  348  347  Older
DateSubjectAuthorDiscuss
04/3/2020
15:40
If you really want a corona virus play, look into (WEY) education online education, benefiting from the global closures of schools/universities dyor as usual



Group turnover for the year to 31 August 2020 is expected to be significantly ahead of market forecasts and to be in excess of GBP7.5m, which would represent an increase of over 25% on the year ended 31 August 2019.

ny boy
04/3/2020
15:39
Albert will be chewed and spat out.
moneymachine2
04/3/2020
15:37
Albert is only a talker.
moneymachine2
04/3/2020
15:34
Looks like 85p new support
iamgreat1
04/3/2020
15:29
Any good shares in undertakers
dazzerman4
04/3/2020
15:23
Go on Albert..
demking1
04/3/2020
15:23
Albert=chimers
andymunchkin
04/3/2020
15:22
As If anyone is going to listen to you.. you are biggest cvnt on ADVFN..Get back to bookies where you belong scrote..
bullrun1
04/3/2020
15:19
Yes we need more kits, and millions to be conservative.... But unlikely to be NCYT's kitThat's why the price is dropping, fundamentals and not shorters ... As I have said repeatedly, the company has missed a great opportunity to be at the forefront of diagnosis, but now is one of the pack
yet another final
04/3/2020
15:17
HungryFer blood
Or thirdtyFer pish. Udecide regardless

andymunchkin
04/3/2020
15:15
@ 15pm itHits 95 ,5is the magicNo.
95-75-55-45-35-25-15

andymunchkin
04/3/2020
15:13
funding investors above.
hazl
04/3/2020
15:12
LyingGames orCryingGames
UDecide

andymunchkin
04/3/2020
15:11
CityBoys upset,theyCouldnt haveTheir way so now theyR hungry fer blood cueIn Sxx
andymunchkin
04/3/2020
15:10
NOVACYT

Has various areas of expertise.
When it was first admitted to the stock exchange....


'admission to the AIM market, today, 1 November 2017, under the ticker "NCYT" (ISIN: FR0010397232).

The Novacyt Group is a rapidly growing, international diagnostics group generating revenues from cancer, haematology, serology and infectious disease products and services. Through its proprietary technology platform, NOVAPrep®, and molecular diagnostic platform, genesig®, Novacyt is able to provide an extensive range of diagnostic products across a broad international distributor network and to major corporate partners. The Company has a strong track record of growth, delivering 56% CAGR between 2014 and 2016.

Summary of the Fundraising

€9.7 million (before expenses) raised through the Fundraising
The Fundraising consisted of €4.7 million of Placing Shares and €5.0 million of Subscription Shares, both at an issue price of 59.38 pence per Share (€0.66) (the “Issue Price”)
The number of Ordinary Shares in issue on AIM Admission will be 37,664,341, giving the Company an anticipated market capitalisation of approximately £22.4 million at the Issue Price

Reasons for Admission and Use of Proceeds

Following the Company's acquisition of Primerdesign in May 2016, the Group has become a more UK-centric company, with clear growth plans. The Directors believe that the admission to AIM is an important step in the Company's development, providing access to a deeper potential pool of capital whilst raising its international and capital markets ......'

hazl
04/3/2020
15:06
'Data include both confirmed and presumptive positive cases of COVID-19 reported to CDC or tested at CDC since January 21, 2020. This table does not include information on testing results of persons repatriated to the United States from Wuhan, China and Japan. States are now testing and publicly reporting their cases. In the event of a discrepancy, state case counts are the most up to date.

† CDC is no longer reporting the number of persons under investigation (PUIs) that have been tested, as well as PUIs that have tested negative. Now that states are testing and reporting their own results, CDC’s numbers are not representative all of testing being done nationwide. '





interesting

hazl
04/3/2020
15:05
TimberR type
andymunchkin
04/3/2020
15:04
Still collecting wood....Watch the space.
albert arthur
04/3/2020
15:01
Hazl manUp
andymunchkin
Chat Pages: Latest  358  357  356  355  354  353  352  351  350  349  348  347  Older

Your Recent History

Delayed Upgrade Clock